Lapsi Health has introduced Keikku 2.0, an FDA-cleared, AI-powered digital stethoscope designed to cut down on clinical paperwork and give physicians more time with patients. The compact, puck-sized device replaces a traditional stethoscope during exams, capturing heart and lung sounds while streaming audio to wireless headphones and recording high-quality waveforms for analysis.
During auscultation, Keikku 2.0 uses built-in AI to flag potential issues, such as heart murmurs or abnormal lung sounds, giving clinicians real-time insights at the point of care. Between exams, it doubles as an AI transcription recorder, automatically drafting structured notes so doctors don’t have to write or type while speaking with patients.
According to Lapsi Health, the system generates SOAP notes enriched with ICD-10, CPT, and other relevant coding, helping streamline billing and documentation. Clinicians can review and edit everything before sending it to the EHR, maintaining full control over the final record. The recorded auscultations are stored alongside the patient’s chart as sound files, creating a clear audit trail and enabling easier follow-up comparisons.
Keikku 2.0 is built with privacy and compliance in mind. It is HIPAA- and GDPR-compliant, aligning with data protection standards across major healthcare markets. The device also offers practical advantages for daily use, including up to 72 hours of battery life on a single charge.
With a price of $375 and availability directly from Lapsi Health, Keikku 2.0 aims to be an accessible upgrade for clinics seeking to modernize auscultation and documentation workflows. For busy practices tackling administrative overload, an AI-enabled digital stethoscope that listens, analyzes, and documents could be a meaningful step toward faster, more accurate patient care.
